Matters to be Discussed. Discussions with employees and, where they choose, their representatives will include, where relevant, discussion of:
a) measures that could be taken to remove or reduce the incidence of an employee becoming excess;
b) redeployment prospects for the employee concerned;
c) the appropriateness of using voluntary retrenchment; and
d) the method of identifying an employee as excess, having regard to the efficient and economical working of the agency, and the relative efficiency of employees.
Matters to be Discussed. Any matter not stipulated in this agreement will be determined from time to time after consultation between Party A and Party B.
Matters to be Discussed. The meeting will include the review, discussion, and Contact Person For More Information: Xxxx
Matters to be Discussed. Agenda items will include a dialogue on issues that are
Matters to be Discussed. The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement 00074.
Matters to be Discussed. The meeting will include the review, discussion, and evaluation of grant applications to fund two new Prevention Research Centers received in response to Program Announcement #01101.
Matters to be Discussed. Agenda items include: Childhood Lead Poisoning Prevention activities update, Medicaid issues, Screening and Case Management Working Group updates, and updates on Medical and Environmental Management issues. Agenda items are subject to change as priorities dictate. Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
Matters to be Discussed. Agenda items will include updates from CDC Director, Xxxxx Xxxxxxx, M.D., Ph.D., followed by committee discussion on strategic thinking about the Contact Person For More Information: Xxxxx Xxx XxXxxxx, Acting Executive Secretary, Advisory Committee to the Director, CDC, 0000 Xxxxxxx Xxxx, NE, M/S Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
Matters to be Discussed. Agenda items include issues pertaining to the epidemiology and control of Tuberculosis in low incidences counties and TB research priorities. Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). Name: National Vaccine Advisory Committee (NVAC). Times and Dates: 9 a.m.–2:15 p.m., May 22, 2000; 8:30 a.m.–12:45 p.m., May 23, 2000. Place: Xxxxxx X. Xxxxxxxx Building, Room 505A, 000 Xxxxxxxxxxxx Xxxxxx, XX, Xxxxxxxxxx, XX 00000. Status: Open to the public, limited only by the space available.
Matters to be Discussed. Agenda items will include: an update on the National Vaccine Program Office (NVPO) activities; an
